BRIEF published on 11/14/2024 at 09:05, 7 days 5 hours ago Novem Group S.A.: Impacted Half-Year Results Amid Challenging Market Conditions Financial Results Market Conditions Revenue Drop Novem Group Net Leverage
PRESS RELEASE published on 11/14/2024 at 09:00, 7 days 5 hours ago Novem Group S.A.: HY 2024/25 figures reflect continued adverse market environment Novem Group S.A. reports HY 2024/25 figures with revenue decline of 19.5% compared to previous year, impacted by weak demand in Europe and Asia. Adj. EBIT decreased by 31.1% year-on-year Europe Revenue Decline Novem Group S.A. Asia HY 2024/25
BRIEF published on 11/07/2024 at 09:05, 14 days 5 hours ago Novem Group to Announce HY 2024/25 Results Conference Call Investor Relations Webcast Half-year Results Novem Group
PRESS RELEASE published on 11/07/2024 at 09:00, 14 days 5 hours ago Novem Group S.A.: Invitation to the HY 2024/25 results presentation on 14 November 2024 Novem Group S.A. invites investors to the HY 2024/25 results presentation on 14 November 2024, with CEO and CFO presenting the half-year results. Follow the event via webcast or conference call Conference Call Investors Webcast Novem Group HY 2024/25 Results
BRIEF published on 10/02/2024 at 19:20, 1 month 18 days ago Novem Group S.A. Receives Potential Delisting Acquisition Offer Frankfurt Stock Exchange Delisting Shareholder Offer Novem Group Automotive Investments
PRESS RELEASE published on 10/02/2024 at 19:15, 1 month 18 days ago EQS-Adhoc: Novem Group S.A.: Potential delisting acquisition offer for the shares and potential delisting Novem Group S.A. is considering a potential delisting acquisition offer for shares and delisting from the Frankfurt Stock Exchange, pending board approvals. More updates to follow Shares Frankfurt Stock Exchange Delisting Novem Group S.A. Acquisition Offer
BRIEF published on 08/22/2024 at 16:35, 2 months 29 days ago Novem Group S.A.: Annual General Meeting Approves All Items on the Agenda Annual General Meeting Voting Results Dividend Supervisory Board Novem Group
PRESS RELEASE published on 08/22/2024 at 16:30, 2 months 29 days ago Novem Group S.A.: Annual General Meeting approves all items on the agenda Novem Group S.A. shareholders approve all agenda items at the Annual General Meeting, appoint new Supervisory Board member, and decide not to distribute dividend for FY 2023/24 due to market conditions Annual General Meeting Shareholders Dividend Novem Group S.A. New Member
BRIEF published on 08/14/2024 at 09:05, 3 months 7 days ago Novem Group S.A.: Q1 2024/25 Figures Show a Soft Start to the Year Financial Performance Market Conditions Revenue Decrease Q1 Results Novem Group
PRESS RELEASE published on 08/14/2024 at 09:00, 3 months 7 days ago Novem Group S.A.: Q1 2024/25 figures show a soft start to the year Novem Group S.A. reports a soft start with Q1 2024/25 figures showing a revenue decline of 20.0% and Adj. EBIT decrease of 29.2% compared to the previous year amidst challenging market conditions Financial Results Revenue Decline Novem Group S.A. Challenging Market Conditions Q1 2024/25
Published on 11/21/2024 at 14:00, 10 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 13:30, 40 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 40 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 10 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 10 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 12:35, 1 hour 35 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 55 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 12 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 50 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 25 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 25 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
